Immunocore Holdings Ltd (IMCR) — Cash Flow Reinvestment Rate
Immunocore Holdings Ltd (IMCR) has a Cash Flow Reinvestment Rate of 1.19x as of June 2025, reinvesting $30.83 Million (capex $414.00K plus investments $-30.41 Million) from operating cash flow of $25.96 Million. See Immunocore Holdings Ltd (IMCR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Immunocore Holdings Ltd Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for Immunocore Holdings Ltd across 2 annual periods. For the full cash flow conversion analysis, see Immunocore Holdings Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Immunocore Holdings Ltd (2023–2024)
Year-by-year capital reinvestment analysis for Immunocore Holdings Ltd. See Immunocore Holdings Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 13.83x | $360.30 Million | $26.06 Million | $5.17 Million | ▲ +298.1% |
| 2023 | 3.47x | $10.21 Million | $2.94 Million | $5.42 Million | — |